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Abstract 
The low engraftment and retention rate of mesenchymal stem cells (MSCs) at the target 
site indicates that the potential benefits of MSC-based therapies can be attributed to their paracrine 
signaling. In this study, the influence of decellularized extracellular matrices (dECM) on pro-
angiogenic signaling of MSC was investigated. Effect of cell passage number on ECM secretion 
and subsequently, on regulation of MSC secretome was also explored. The study revealed 
upregulated expression of angiogenesis-related factors upon culturing MSCs on dECMs 
irrespective of media supplementation. In addition, dECM generated in presence of ascorbic acid 
promoted expression of angiogenic molecules as compared to dECM derived in absence of media 
supplementation. Further, it was observed that the effectiveness of dECM to stimulate angiogenic 
signaling of MSCs was reduced as cell passage number was increased from P3 to P5. The activity 
of MSC-secreted biomolecules investigated by assessing the proliferation as well as capillary 
morphogenesis of human umbilical vein endothelial cells (HUVECs) supported the Proteome 
Profiler data. Working towards the goal of creating a biomaterial capable of recapitulating the 
multifactorial aspects of the stem cell environment, ECM deposited by MSCs was collected and 
introduced into alginate solution to create a hybrid material. Alginate concentration was varied 
while keeping the dECM concentration constant. Swelling ratio, degradation and diffusion of the 
hybrid hydrogels were explored in comparison to dECM-free (alginate only) gels. Results found 
that both degradation and diffusion characteristics were impacted by the introduction of matrix 
proteins. Lastly, the printability of the hybrid hydrogels at various printing pressures was also 
explored using Cellink’s INKREDIBLE bioprinter. Optimal printing pressures for each bioink 
xi 
 
composition was explored, and it was revealed that dECM addition improved the bioink’s 
printability at lower printing pressures in comparison to dECM-free gels. 
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Chapter 1: Introduction 
Tissue Engineering  
 Tissue engineering is an interdisciplinary field that aims to fabricate constructs that can 
regenerate, maintain, or improve the functions of damaged tissue. The field heavily depends on 
coalescing cells, bioactive molecules, and biomaterials (scaffolds) to organize tissue restoration 
and integration with a host environment [1]. Within functional tissues, cells are the main building 
blocks, secreting its own support structures, referred to as the extracellular matrix (ECM). The 
ECM not only provides mechanical support for cells, but it also functions as a foundation for 
interactions with various signaling molecules that elicit and direct cell responses and behaviors 
(including survival, motility, and growth) [2]. In the field of tissue engineering, researchers try to 
mimic such interactions by creating a scaffold that hosts cells in presence of biomolecules to 
promote growth and regeneration. 
 Throughout the last few decades, research and development in tissue engineering has 
tackled a wide array of tissue types. Advancements have been made in the regeneration of heart, 
bone, eye, and many other areas. Even though much progress has been accomplished, further 
research is still required. Complex organ tissues, such as the lung, have been successfully 
developed within the laboratory, but the development is at the nascent stage and the clinical study 
involving transplantation within human body is yet to be initiated [1]. Apart from tissue and organ 
restoration, this field has been growing in the application of modeling human physiology in vitro. 
The creation of tissue models within the lab allow for researchers to study the complex in vivo 
mechanisms that direct cellular and pathological processes [3]. These tissue engineered models, 
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by improving the understanding of physiological and pathological processes, permit the 
development of new drugs. Even further, tissue engineering concepts are also being heavily 
utilized in cancer research through the fabrication of tumor models to allow researchers to better 
understand how tumors progress [3]. 
With the promise of tissue engineering in medical therapeutic advancements, it is crucial 
for researchers to continue to make progress in the creation of tissues in vitro. Towards this, 
optimization of biomaterials by tailoring its mechanical and regeneration properties for specific 
applications is crucial. Scaffolds need to be further developed to fully imitate the complex tissue 
architecture and vascular networks that are found in native tissue.  
Biomaterials for Tissue Engineering 
 As an integral component of tissue engineering, the field of biomaterials is focused on 
developing materials that encourage cell growth, cell maintenance, and restoration of tissue. 
Developments in biomaterials are continuing in the direction of promoting regeneration through 
the utilization of biomechanical, biochemical, and biophysical cues [3]. Biomechanically, this field 
focuses on mimicking the properties of native ECM as cells are able to sense matrix stiffness and 
influences their bioactivity. Biochemically, researchers have been encouraging signaling through 
the binding of growth factors and other important biomolecules to the scaffold to control diffusion, 
which in turn controls cellular activity and intracellular signaling. Lastly, biophysically, 
biomaterials are being designed to give anchorage to cells; for example, the introduction of pores 
within a scaffold allow the cells a place to home as well as pathways to move around [3]. 
For tissue engineering purposes, polymers, ceramics, composites and metals have all been 
utilized as biomaterials. Regardless of the type, when determining the suitability of a scaffold to 
successfully encourage tissue regeneration, different design requirements are to be followed: 
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1) Biocompatibility: Most importantly, a scaffold must be biocompatible, meaning it does not 
elicit a toxic or immunological response when exposed to the body. Any inflammatory 
reaction caused by the biomaterial would be detrimental to the healing process and could 
induce the host to reject the scaffold. 
2) Suitable Mechanical Properties: The biomaterial must provide structural scaffolding that 
simulates the mechanical properties of the target tissue. Even further, scaffold stiffness can 
affect cell proliferation and differentiation, so it is an important parameter to study to result 
in maximal cell expansion in vivo. 
3) Biodegradability: Since most scaffolds utilized for tissue engineering are not permanent, 
the material should be engineered to have a degradation rate similar to the tissue 
regeneration (growth) rate. The tuning of scaffold degradation kinetics is essential to avoid 
failure in the tissue restoration process. If the rate of degradation is too fast, the scaffold 
will not be able to support the cells enough before tissue regeneration. On the other hand, 
if the rate is too slow, it can cause inflammatory responses or necrosis. Lastly, while 
designing degradability, the by-products must be non-toxic and be easily eliminated from 
the body [4].  
4) Bioactivity: It is essential that the biomaterial can interact with the surrounding 
environment/tissue in order to encourage cell adhesion, migration, and proliferation. 
Although not all biomaterials naturally possess a high bioactivity, it can be increased 
through the addition of biomolecules or proteins that encourage pro-angiogenic signaling 
and enhanced proliferation cellular responses. 
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Hydrogels 
As one of the more common biomaterials utilized in biomedical applications, hydrogels 
are water-swollen gels that form 3D hydrophilic, polymeric networks after triggering monomeric 
units to be crosslinked (chemical reaction, exposure to ultraviolet light, etc). Because of their 
extremely hydrophilic structure, hydrogels have the capacity to withhold copious amounts of water 
or fluids. Considering that up to 60% of the human adult body is water [5], this material has 
incredible potential to be used throughout biomedical applications with its use already prominent 
in the fields of tissue engineering, drug delivery, and biosensors. Besides its superior 
hydrophilicity, hydrogels possess other characteristics that make them advantageous biomaterials. 
Such gels are highly biocompatible and by slightly tuning the composition, cross-linking variables, 
or other various factors, hydrogels can be fabricated with tunable biodegradability and material 
properties, such as porosity and mechanical stiffness, to fit applications more accurately. 
 Hydrogels can be classified based on a number of characteristics due to their high degree 
of design and fabrication freedom. For instance, hydrogels can be derived from natural (collagen, 
alginate) or synthetic (poly(ethyleneglycol) diacrylate (PEGDA)) polymers. In tissue engineering 
applications, there is a slight advantage using natural polymers due to its characteristic of 
biological recognition [6]. Such materials can also be classified based on their response to 
environmental stimuli. Conventional hydrogels have a typical swelling behavior when placed in 
aqueous solutions, but “smart” hydrogels can be designed to exhibit a certain mechanical or 
swelling behavior in response to certain stimuli, such as temperature, pH fluctuations or an electric 
field [6]. Lastly, hydrogel durability distinguishes two categories of durable and degradable 
hydrogels, focusing on their stability in physiological environments. 
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 Briefly, hydrogels can be fabricated to exactly fit specific applications, making them 
advantageous materials. Throughout tissue engineering, focus has been placed on developing 
hydrogels to provide structure for cellular organization while tailoring its characteristics to mimic 
natural tissues. Additionally, emphasis has been placed on creating a highly porous structure to 
encourage cell ingrowth and aid in the neovascularization of the hydrogel [6]. Most importantly, 
hydrogels in tissue engineering continue to be improved to better encapsulate and direct cellular 
functions once implanted in a patient. 
Stem Cells in Tissue Engineering 
Background 
Differing from other various cell types within the human body, stem cells are non-
specialized cells, meaning they do not have any structural characteristics to carry out tissue specific 
functions. Stem cells have the ability to give rise, or differentiate, into specialized cells. For 
example, depending on the environmental cues, stem cells can be stimulated to differentiate into 
bone, muscle, or even vascular cells. This characteristic makes them valuable in the field of tissue 
engineering and regenerative medicine. Further, stem cells have the capacity of self-renewal after 
long periods of inactivity through cell division. Unlike other cell types that can only proliferate, 
stem cells can either self-renew to create more stem cells or give rise to specialized cells. 
 Stem cells have been characterized into three categories, which are distinguished by where 
they are derived from as well as their differentiation capacity. Briefly, a description of each stem 
cell type is introduced: 
1) Embryonic Stem Cells: These cells are derived from embryos that have developed eggs 
after being fertilized in vitro [7]. They are considered pluripotent stem cells, meaning they 
possess the ability to differentiate into any cell type in the body.  
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2) Adult Stem Cells: Considered to be multipotent stem cells, these cells can differentiate into 
other cell types, but restricted in its ability. Depending on their tissue of origin, they are 
generally limited to differentiating into more specialized cell types from that tissue or organ 
[8]. There are adult stem cells in nearly every tissue/organ within the human body.  
Hematopoietic stem cells and bone marrow stromal (or mesenchymal) stem cells are two 
examples. Hematopoietic stem cells can form any type of blood cell, where mesenchymal 
stem cells can generate cartilage, bone, or fat cells [7]. 
3) Induced Pluripotent Stem Cells (iPSCs): These cells are pluripotent stem cells derived from 
adult/somatic (terminally differentiated) cells that are reprogrammed through genetic 
manipulation to the pluripotent state. Because this cell type is a relatively new discovery 
(2006), it is yet to be determined of the extent that iPSCs are equivalent to embryonic stem 
cells [8].  
Regardless of their type, all stem cells are important in tissue engineering due to their 
ability to self-renew and to specialize into certain cell lineages when exposed to certain stimuli. 
Specifically, tissue engineering has focused their efforts in creating functional biomaterials with 
appropriate characteristics to control stem cell function and differentiation [9]. Throughout this 
thesis, work was focused on working with and studying mesenchymal stem cells, which will be 
further elaborated.  
Mesenchymal Stem Cells 
Mesenchymal stem cells (MSCs) are multipotent, adult stem cells that are critical to the 
fields of regenerative medicine and tissue engineering. Their ability to differentiate into several 
diverse cell types and their aptitude to home at injury sites make them prime candidates for clinical 
therapeutic applications.  
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The initial discovery of MSCs is credited to the Russian scientist, Alexander Friedenstein. 
In the 1960s, Friedenstein first isolated a fibroblastic cell type from guinea pig and mouse bone 
marrow. These cells were found to have a high replicative capacity and could produce 
multipotential colonies that when heterotopically transplanted, the colonies were capable of 
generating bone and reticular tissue [10]. Later, in the beginning of the 1990s, Arnold Caplan 
coined this fibroblastic cell type as “mesenchymal stem cells” and proved that these cells could 
also generate adipose tissue, cartilage, tendons, and muscle [11].  
In addition to their self-renewal properties as elaborated by Friedenstein and Caplan, MSCs 
were found to impact the surrounding microenvironment through their secretion of numerous 
growth factors, both autocrine and paracrine. Such released factors decreased inflammation at 
target sites, enhanced tissue repair, and promoted angiogenesis. Even further, it was discovered 
that MSC possess high immunosuppressive properties, which permits them to be transplanted into 
a patient without any prior or after treatment [12]. 
These groundbreaking discoveries resulted in a pursuit to further investigate the therapeutic 
potential of MSCs, leading to the development of many cell-based therapies. Such therapies have 
been developed for the restoration of tissue and organ integrity. Even further, MSC-based therapies 
are being tested to control numerous diseases, such as diabetes, ischemic heart disease, 
osteogenesis imperfecta, and various autoimmune diseases (GvHD, Crohn’s, Multiple Sclerosis, 
etc.) [13]. Because of their therapeutic versatility, MSCs remain a significant therapeutic candidate 
for regenerative medicine and tissue engineering. 
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Chapter 2: Motivation and Objectives 
Even though MSCs show promise for regenerative therapies and tissue engineering 
applications, there remains a critical problem in the clinical translation of cellular therapy. When 
MSCs are injected directly into the target site, there is a low retention and engraftment rate due to 
the harsh microenvironment the cells are subjected to. At such target sites, MSCs can be faced 
with death promoting stimuli, such as reactive oxygen species, hypoxia, deficiency of extracellular 
matrix for MSC attachment, and cytotoxic cytokines [14,15]. Thus, the low survival rate of MSCs 
in such harsh conditions negates the claim that injecting donor MSCs into a patient will result in 
functional integration with damaged tissue to aid in the restoration process. Overall, this is 
compromising the utilization of MSC-based therapies. 
Alternatively, evidence suggests that bioactive factors secreted by MSCs play a critical role 
in reparative processes [16-18]. Biomolecules, such as growth factors, angiogenic factors, 
cytokines, hormones, chemokines, and extracellular matrix proteases, comprise the MSC 
“secretome” and are potentially involved in MSC-mediated tissue/organ restoration [16-18]. The 
potential benefits of MSC-secretome span from vascularization, matrix remodeling to anti-
inflammatory and anti-fibrotic effects [19-21]. Thus, harnessing MSC secretome can potentially 
enhance the efficacy of the cellular therapies.  
Current methods for modulation of MSC secretome include pharmacological, 
physiological (hypoxic or anoxic), or growth factor/cytokine pre-conditioning. Some of these pre-
conditioning methods are accompanied with genetic manipulations prior to transplantation [22-
24]. While these strategies have shown promise in inducing expression and secretion of pertinent 
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factors, they are limited by transient effects (physiological or pharmacological preconditioning) 
post-transplantation and by challenges associated with clinical translation due to viral modification 
of the target gene (genetic manipulation). In addition, none of these pre-conditioning methods can 
improve the limited engraftment and viability of MSCs in situ. 
On the other hand, biomaterial-based approaches result in an enhanced control of cells and 
presentation of MSC secretome [25-32]. Cell encapsulation provides a protective environment for 
the cells against the components of the immune system while permitting transport of nutrients, 
oxygen, and released therapeutic factors [33-35]. Several biomaterials, such as alginate, 
hyaluronan, collagen, fibrin, laminin, and poly (ethylene glycol) (PEG), have been utilized as cell 
delivery vehicles [36-40]. However, there is a limited capability of these matrices to support 
cellular viability and function over an extended period of time, which in turn, hinders 
commercialization of cell-encapsulation-based technologies.  
Biomaterials capable of recapitulating the multifactorial aspects of extracellular 
components of the stem cell environment could enhance the therapeutic capacity of MSCs. The 
local microenvironment of MSCs, a dynamic “niche”, is known to regulate and maintain MSC 
homeostasis. A significant component of the stem cell niche is the extracellular matrix (ECM) 
[41], which is comprised of a vast array of collagens, proteoglycans, glycosaminoglycans, and 
other various structural proteins (fibronectin, elastin, laminin, etc.) that together provides support 
for cells to function and interact as well as providing a substrate for cell migration [42].   
Not only does the ECM provide a mechanical platform, it also supports and regulates 
various cellular processes through its ability to bind interacting biomolecules, allowing the ECM 
to mediate in copious biological processes, such as growth factor receptor signaling and chemical 
signaling pathways. Research has found that ECM controls MSC fate through activating 
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intracellular signaling through adhesion molecules, regulating the activity of soluble and insoluble 
factors, and implementing mechanical stimulation [41]. For instance, it was found that MSCs 
cultured on decellularized ECM (dECM) in comparison to being cultured on tissue culture plates 
resulted in a more prominently induced MSC differentiation (both adipogenic and osteogenic), 
indicating that the ECM provided cues and signaling pathways to enhance induced differentiation 
[43]. 
Due to ECM’s critical role in stem cell fate (self-renewal and differentiation), this research 
hypothesizes that the biochemical cues of ECM influence the paracrine activities of MSCs. 
Regulating these biochemical cues would permit optimization of MSC-based therapies via 
improved MSC viability and enhanced harnessing of MSC secretome. Therefore, this work 
explores the effect of dECM on guiding paracrine activities of MSCs and introduces the idea of 
developing a bioink based on MSC-derived dECM. Research in this study addressed four 
objectives, working towards the goal of creating a biomaterial capable of recapitulating the 
multifactorial aspects of the stem cell environment: 
Objective 1: Characterize MSC-derived dECM - The composition of ECM secreted 
from bone marrow-derived human MSCs was analyzed while also investigating the 
effect of passage number and ascorbic acid supplementation on its deposition 
Objective 2: Explore the effect of dECM on bioactivity and paracrine signaling - 
MSCs were seeded on top of dECM to study the proliferative activity. Conditioned 
media from the MSCs seeded on top of dECM was collected, and the concentration 
of MSC-secreted pro- and anti-angiogenic molecules was determined. The 
bioactivity of MSC-secreted biomolecules was investigated by assessing the 
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proliferation as well as capillary morphogenesis of human umbilical vein 
endothelial cells (HUVECs). 
Objective 3: Fabricate hybrid hydrogel - Alginate hydrogels of varying 
concentrations (2.5%, 5%, and 7%) were synthesized with and without 30 µg/mL 
of ECM proteins. The impact of ECM addition on the hydrogel’s swelling ratio, 
degradation and diffusion was documented while demonstrating the effects of 
alginate concentrations. 
Objective 4: Test printability of dECM hydrogel – Hybrid hydrogels were printed 
using Cellink’s INKREDIBLE bioprinter. The printed results were imaged and 
analyzed to explore the printability and optimum printing pressure for each of the 
bioink concentrations. 
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Chapter 3: Characterization of dECM 
Introduction  
 The ECM is a complex and dynamic network comprised of a vast array of collagens, 
proteoglycans, and other various structural proteins (fibronectin, elastin, laminin, etc.) that 
together provide support for cells to function and interact as well as providing a substrate for cell 
migration [42]. Because of its complex nature, it is important to characterize the resultant dECM 
gathered from MSCs that was used throughout all studies within this thesis.  
Before exploring dECM components, it was necessary to first confirm that the protocol 
used for decellularization successfully removed MSCs from their deposited ECM. After such 
confirmation, experiments were carried out to explore MSC deposition of collagen, fibronectin, 
and laminin, which are three abundant proteins in ECM. Furthermore, the concentration of 
glycosaminoglycans (GAGs) deposited by MSCs was investigated. GAGs are also an important 
component of ECM by regulating cell-matrix interaction through modulating the localization and 
presentation of growth factors and morphogens [44]. 
Since culture conditions can strongly influence the deposition and organization of ECM, 
the impact of ascorbic acid on ECM deposition was investigated in this study. Previous work 
conducted by Prewitz et al. suggested that ascorbic acid supplementation enhanced the deposition 
of MSC-derived ECM [45]. Therefore, the influence of culturing MSCs with or without ascorbic 
acid supplementation on ECM composition was explored. 
In addition, to investigate the effect of cell passage on the deposition of ECM MSC passage 
number was varied from 3 to 5. In an earlier study, compositional changes had been identified 
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within dECM as a function of MSC age [46]. Studies have also demonstrated dECM derived from 
low passage cells promotes expansion of primary MSCs; however, dECM generated from aged 
MSCs loses the potency [46-47]. Taking into account that subcultured cells at different passages 
deposit ECM with different expression patterns, the effect of these variations on dECM was 
investigated.  
Methods  
Preparation and Decellularization of ECM  
150,000 MSCs were seeded in each well of 6 well plates. The passages were varied from 
3 to 5. Upon confluency, the cells were cultured in normal culture medium with or without ascorbic 
acid (50 µg/mL, Sigma-Aldrich). After 10 days, the wells were treated with 0.5% Triton-X-100 
(Sigma-Aldrich, USA) in 20 mM ammonium hydroxide (NH4OH, Fischer Scientific, USA) for 10 
minutes at 37⁰C. Following which the wells were rinsed with Dulbecco’s Phosphate Buffered 
Saline (DPBS, Gibco, New York) for 5 minutes and treated with 200 µ/mL DNase I, RNase-Free 
(OPTIZYME, Fisher BioReagents), for 60 minutes at 37 ⁰C. The ECM layers were washed with 
DPBS and allowed to air dry overnight. Plates were stored at -20⁰C until further use.  
Confirmation of Decellularized ECM Layers 
To confirm decellularization, MSCs were stained with 1% (v/v) Hoechst 33342 (Thermo 
Scientific, Germany) nucleic acid dye prior to treatment with Triton X-100. Images were captured 
before and after decellularization via laser scanning confocal microscope (Olympus, FV1200). 
DNA Quantification 
 The amount of DNA present in dECM samples both before and after decellularization and 
DNase treatment was quantified using Quant-iT™ dsDNA High-Sensitivity Assay Kit (Thermo 
Fisher, USA). Briefly, DNA was extracted from the samples using papain extraction reagent. To 
14 
 
create the papain extraction solution, 0.1M sodium acetate, 0.01M Na2ETDA (EMD Millipore 
Corporation, USA), and 0.005M cysteine hydrochloride were added to 0.2M sodium phosphate 
buffer (sodium phosphate monobasic and sodium phosphate dibasic). Once all the components 
were completely dissolved, papain suspension (Sigma-Aldrich, USA) was added to the extraction 
buffer and stored at 4⁰C for a maximum of 10 days. Papain extraction solution was then added to 
the samples and incubated at 37⁰C for 3 h. After digestion, samples and DNA standards were added 
to a black sided, clear bottom 96 well plate. Working reagent was made per manufacturer’s 
instructions and added to samples/standards. Fluorescence readings were measured using a 
microplate reader (SpectraMax M3, Molecular Devices) at excitation and emission wavelengths 
of 480 nm and 530 nm, respectively.  
Immunofluorescence 
MSCs were cultured on Lab-Tek chamber slides (Thermo Fisher Scientific) and 
decellularized as described earlier. dECM was fixed using a 50% methanol (Fisher Scientific, 
Canada) and 50% acetone (Fisher Scientific, USA) solution for 20 minutes at -20⁰C. Wells were 
washed with DPBS and blocked with 5% bovine serum albumin (BSA, Sigma-Aldrich, USA) for 
1 h at room temperature on an orbital shaker. Samples were rinsed and incubated overnight at room 
temperature with COL1A1 antibody (Santa Cruz Biotechnology), monoclonal anti-fibronectin 
antibody (Sigma), or with laminin polyclonal antibody (Thermo Fisher Scientific). Wells were 
rinsed with DPBS and then incubated with secondary antibodies for 1 h at room temperature. The 
samples were then rinsed, and confocal images were captured. 
Soluble Collagen Assay 
The collagen concentration was determined, in collected dECM samples, using Soluble 
Collagen Assay Kit (Cell BioLabs, Inc., California). Initially, the dECM samples were treated with 
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0.5 mg/mL of pepsin (Sigma-Aldrich, USA) solution in 0.5 M acetic acid overnight at 4⁰C. 
Digested aliquots were transferred from the wells into a 96 well plate. Following which, the 
samples and the assay’s collagen standards were evaporated to dryness in 37⁰C overnight. Sirius 
Red reagent was added to the samples and collagen standards to stain collagen’s triple helix 
structure, for 1 h as per manufacturer’s instructions. The stained wells were washed and incubated 
with an extraction solution to transfer the eluted dye to a new plate. The amount of collagen was 
measured using a plate spectrophotometer (Eon, BioTek). 
sGAG Assay 
Sulfated glycosaminoglycan (sGAG) was quantitatively determined using 
Glycosaminoglycans Assay Kit (Chondrex, Inc., Washington). sGAG were extracted from the 
dECM samples using papain extraction reagent, incubating at 37⁰C for 3 h. Digested aliquots were 
collected from the wells and mixed with 1,9 Dimethylmethlyene (DMB) Dye Solution as per 
manufacturer’s instructions. The concentration of GAGs in samples were determined using the 
Eon plate spectrophotometer and regression analysis. 
Results and Discussion 
The decellularization method involving treatment with 0.5% Triton X-100 in 20 mM 
NH4OH proved to be successful according to the images displayed in Figure 1. Prior to treatment, 
Hoechst staining as well as phase contrast images confirmed confluency with well-defined cell 
nuclei of MSC cultures (Figure 1 A and B). After treatment, the decellularization solution lysed 
the MSCs, removing any presence of cell nuclei that was evident in the prior Hoechst stain image. 
Phase contrast images revealed that the detergent left the ECM layer intact as a web-like, protein 
network remained at the bottom of the decellularized well.  
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Figure 1. Confirmation of decellularization and deposition of dECM. MSCs were stained with 1% (v/v) 
Hoechst nucleic acid dye 10 days post-confluence, and images were captured. Hoechst images (scale bar 
of 100µm) (A) and phase contrast images (scale bar of 500µm) (B) confirmed confluency prior to 
decellularization. Lack of Hoechst staining confirmed removal of cellular nuclei and genetic material (C), 
and phase contrast image revealed the remaining deposition of ECM after the removal of cells (D). 
 
Interestingly, DNA quantification indicated that the decellularization process did not rid 
the matrices of DNA (Figure 2). Quantification of DNA was normalized to the concentration of 
DNA found in living cells (i.e. before decellularization), which acted as the positive control. After 
decellularization, around 70% of DNA remained in the ECM that was not treated with DNase. On 
the other hand, incubation of the matrices with DNase for an hour reduced DNA content in 
comparison to positive control and dECM without DNA removal. 
A B 
C D 
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Figure 2. DNA quantification of decellularized matrices. Results presented as percent DNA concentration 
with respect to the DNA content within the cells prior to decellularization. Quantification was carried out 
on decellularized matrices treated with DNase (dECM + DNase) and without DNase treatment (dECM-
DNase). 
 
 Since the decellularization protocol proved to be successful without visibly impacting the 
ECM, characterization of MSC-derived ECM was carried out. Decellularized matrices generated 
by MSCs (P4) with and without ascorbic acid supplementation were stained for collagen, 
fibronectin, and laminin. Immunofluorescence staining (Figure 3) showed that the ECM structural 
proteins were present in abundance with collagen and fibronectin being more prominent than 
laminin. In accordance with recent studies [45], this staining demonstrated that ascorbic acid 
supplementation influenced the secretion and deposition of such ECM components. All three ECM 
proteins showed an increased deposition when MSCs were supplemented with ascorbic acid during 
cell culture.   
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Figure 3. Immunofluorescence staining to compare the effect of ascorbic acid on ECM deposition. MSCs 
(P4) were decellularized 10 days post-confluence, and cell-free matrices were stained for collagen (A), 
fibronectin (B), and laminin (C). Scale bar: 100 µm.  
 
In addition to imaging, the concentrations of collagen and GAGs in the deposited matrices 
was also quantitatively studied while varying media supplementation and passage number (Figure 
4). In both assays, a passage-related reduced expression of collagen and GAGs was observed. This 
observation is in line with earlier studies which demonstrated ECM development is dependent on 
the passage number of the cells [48]. Further, consistent with other studies, data also demonstrated 
+ Ascorbic Acid - Ascorbic Acid 
Laminin 
Fibronectin 
Collagen 
A 
B 
C 
19 
 
an enhanced amount of sulphated GAGs within the secreted matrices in the presence of ascorbic 
acid. The overall content of GAGs strongly influences the presentation and functionality of growth 
factors and thus, plays a critical role in the guiding the behavior of adherent cells. However, the 
enhanced expression was not statistically significant (p-value > 0.05). 
 
     
 
Figure 4. Effect of passage number on the composition of MSC-derived dECM generated with (+AA) or 
without (-AA) ascorbic acid supplements. Comparison of the deposition of collagen (A) and GAGs 
(chondroitin-6-sulfate) secretion (B) as a function of cell passage number in the presence and absence of 
media supplementation. Error bar S.E.M (N=3).  *p-value<0.05 with respect to P3 dECM, +AA 
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Chapter 4: Effect of dECM on Bioactivity and Paracrine Signaling 
Introduction 
ECM not only provides a highly organized lattice where cells reside and interact with each 
other, but also plays an important role in regulating the behavior of cells including migratory, 
proliferative, and metabolic activities [49]. Studies have demonstrated that when cells are cultured 
on ECM in vitro, they display growth characteristics, morphology, as well as biological behaviors 
which were not observed when harvested on artificial plastic, glass substrate, or TCP coated with 
isolated ECM components [13]. Studies employing decellularized matrices from epithelial cells, 
endothelial cells, fibroblasts as well as adult bone marrow stem cells for MSC expansion, 
corroborated that decellularized matrices offer superior substrates for proliferation of cells in 
contrast to traditional methods [49-51]. Thus, the following work explores the bioactivity of MSCs 
when seeded on dECM generated in the presence or absence of ascorbic acid supplements and as 
a function of passage number. 
Although the cell-instructive characteristics of ECM and subsequent effect in regulation of 
stem cell fate is well known [52], its role in guiding the paracrine signaling of stem cells is still 
underappreciated. Here, it is explored how dECM impacts MSC paracrine signaling through the 
investigation of MSC-secreted pro- and anti-angiogenic molecules released in culture media via a 
human angiogenesis antibody assay. The bioactivity of MSC-secreted biomolecules was then 
studied by assessing the proliferation as well as capillary morphogenesis (via Matrigel culture) of 
HUVECs. Effect of passage number and ascorbic acid supplementation on dECM and MSC 
paracrine signaling was also investigated.  
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Methods  
Proliferation Assay of MSCs on dECM 
3,000 MSCs (passage 4, P4) were seeded on top of the air-dried dECMs (generated in the 
presence and absence of ascorbic acid) and cultured in normal culture medium for 48 h. Following 
which the proliferative activity of the MSCs were measured using XTT Cell Proliferation Assay 
Kit (ATCC). MSCs seeded on the tissue culture plate (TCP) acted as a control. The proliferation 
of MSCs on dECMs were expressed as percent growth over the control.  
Angiogenesis Profiling of dECM Condition Media 
150,000 MSCs (P4) were seeded on air-dried dECM (generated with and without ascorbic 
acid) in normal culture medium. Cells seeded on TCP acted as a control. After 24 h, the media was 
replaced with serum-free medium. The spent/conditioned media was collected after 48 h and was 
stored at -20⁰C until further use. The concentrations of pro- and anti-angiogenic molecules in the 
conditioned media were determined via Proteome ProfilerTM Human Angiogenesis Antibody 
Array (R&D Systems) as per manufacturer’s instructions.  
Proliferation of HUVECs 
The activity of MSC-secreted biomolecules was investigated by assessing the proliferation 
of HUVECs. Conditioned media from MSCs (P4) seeded on top of dECMs was collected and 
concentrated using Vivaspin concentrators (2,000 MWCO, Sartorius). 20,000 HUVECs were 
seeded in the wells of a 96 well plates in the presence of the conditioned media. HUVECs harvested 
in presence of normal culture medium acted as control. After 48 h, XTT proliferation assay was 
utilized to measure proliferative activity of HUVECs.  
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Capillary Morphogenesis of HUVECs 
 50 μL of Geltrex TM LDEV-Free Reduced Growth Factor Basement Membrane Matrix 
(Gibco) was pipetted into the wells of 96 well plates and incubated at room temperature. 50,000 
HUVECs were seeded onto the gels and incubated in the presence of MSC conditioned media and 
normal HUVECs culture medium at 37 ⁰C and 5% CO2. After incubating for 15 h, images of the 
capillary sprout formations were captured via Zeiss Axio Observer A1 microscope with integrated 
CCD camera, and the number of sprouts per image was counted. 
Results  
The influence of dECM, generated as a function of passage number and media 
supplementation with ascorbic acid, on MSC proliferation was assessed. For the purpose, P4 MSCs 
were seeded on dECM as culture surfaces and TCP (control). The proliferative activity was 
measured via XTT proliferation kit. As demonstrated in Figure 5, seeding MSCs on top of dECM 
increased proliferative activity compared to control. Interestingly, MSCs seeded on P4 dECM, 
both with or without ascorbic acid, had the highest percent growth (p-value < 0.05).  
 
 
Figure 5. Effect of dECM generated by MSCs (P3-P5) in the presence (+AA) or absence (-AA) of ascorbic 
acid on proliferation of MSCs (P4).  The cell growth was normalized with respect to control (TCP). Error 
bar S.E.M (N=3). #p-value<0.05 with respect to P4 ECM, +AA; *p-value<0.05 in respect to TCP 
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To investigate the efficacy of dECM generated by MSCs at different passages with and 
without media supplementation in promoting angiogenic signaling, MSCs (P4) were seeded on top 
of dECM (P3-P5). MSCs seeded on TCP (no ECM) acted as the control.  The concentration of 55 
pro- and anti-angiogenic molecules in the conditioned media was determined using Proteome 
ProfilerTM Human Angiogenesis Antibody Array. As demonstrated in Figure 6A and B, compared 
to the control (no ECM), expression of angiogenesis-related factors was upregulated (relative 
expression > 1.5) when MSCs were harvested on dECM irrespective of media supplementation 
for all the passages of MSCs studied. However, the relative expression of different angiogenic 
molecules varied as a function of passage number of MSCs. Further analysis revealed, dECM 
generated in presence of ascorbic acid promoted expression of angiogenic molecules as compared 
to dECM derived in absence of media supplementation (Figure 6C). When the effect of dECM-
derived from MSCs of different passages on angiogenic signaling was compared, it was observed 
that at lower passage number (P3 dECM) the expression of majority of pro-angiogenic molecules 
were upregulated. The effectiveness of dECM to stimulate angiogenic signaling of MSCs reduced 
as passage number was increased from P3 to P5. 
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Figure 6. Effect of dECM passage number on angiogenic signaling of MSCs. The expression of angiogenic 
factors when P4 MSCs were seeded on dECM generated by P3-P5 MSCs in the absence (A) and presence 
(B) of ascorbic acid relative to TCP (control). The concentration of factors secreted by MSCs seeded on 
P3-P5 dECM supplemented with ascorbic acid were also normalized to the molecules secreted by MSCs 
seeded on dECM without ascorbic acid (C). The dotted lines correspond to the relative expression of 1.5 
 
 
To assess the bioactivity of factors released by MSCs after being seeded on varying dECM 
passages (P3-P5), the impact of conditioned media on proliferation and capillary morphogenesis 
of HUVECs was investigated. Endothelial cell culture medium supplemented with growth factors 
B 
C 
A 
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and conditioned media collected from MSCs seeded on TCP (no ECM) acted as the positive and 
negative controls, respectively. As demonstrated in Figure 7, compared to the negative control, 
conditioned media collected from MSCs cultured on dECM enhanced proliferation of HUVECs 
irrespective of passage number and media supplementation. Upon comparing the impact of 
passage number, maximal proliferation was observed when HUVECs were incubated in 
conditioned media collected from MSCs seeded on dECM generated by P4 cells (p-value < 0.05). 
 
 
Figure 7. Investigation of activities of factors secreted by P4 MSCs upon seeding on dECM generated by 
P3-P5 MSCs in the presence (+AA) and absence (-AA) of ascorbic acid. Proliferation of HUVECs in 
presence of conditioned medium was normalized with respect to HUVECs culture media. Error bar S.E.M 
(N=3). #p-value<0.05 with respect to P4 dECM, + AA; ^p-value<0.05 with respect to P4 dECM, - AA 
 
 
To evaluate the influence of MSC-secreted molecules on capillary morphogenesis, the total 
number of sprouts per image was measured (Figure 8). The conditioned media collected from 
MSCs seeded on P3 and P4 dECM generated in presence of ascorbic acid stimulated maximal 
sprouts formation (p-value < 0.05) in comparison to the positive control (HUVECs). 
26 
 
 
 
 
 
Figure 8. Analysis of activities of factors secreted by P4 MSCs upon seeding on dECM generated by P3-
P5 MSCs in the presence (+AA) and absence (-AA) of ascorbic acid. A) Number of sprouts formed per 
image was measured to assess capillary morphogenesis of HUVECs in presence of conditioned medium. 
HUVECs culture media was the positive control, and conditioned media collected from MSCs seeded on 
TCP (no ECM) acted as the negative control. *p-value<0.05 with respect to HUVECs (positive control). 
B) Typical phase contrast images of the sprouting obtained upon incubating HUVECs with culture 
medium and conditioned media collected from MSCs seeded on P3 dECM + AA, P3 dECM - AA, and no 
ECM. 
 
Discussion 
In this study, the influence of ECM in stimulating pro-angiogenic activity of MSCs was 
explored. The compositional heterogeneity in ECM has been attributed to stem cell fate and thus, 
it seems likely that the activity and secretory signature of MSCs will be altered in presence of 
ECM with varying biological complexity. To validate the advantages of employing MSC-derived 
P3 - AA HUVECs P3 + AA No ECM 
B 
A 
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ECM in regulating the behavior of stem cells, P4 MSCs were harvested on dECM generated in the 
presence or absence of ascorbic acid. In this work, consistent with other studies, an enhanced 
proliferation of MSCs was observed in the presence of dECM compared to TCP [47,53]; however, 
no difference was observed between dECMs as a function of media supplementation. Interestingly, 
maximal cell growth was observed was dECM generated by P4 MSCs. In contrast to this 
observation, an earlier study reported better performance of the ECM generated by passage 3 cells 
compared to passage 4 in terms of cell yield [47]. However, this difference in observation can be 
attributed to utilization of MSCs from different sources. The previous study analyzed the 
proliferation of adult MSCs on ECM generated by human fetal MSCs, where the presented work 
focuses on dECM secreted by adult MSCs [47]. 
Investigation of the influence of dECM on angiogenic signaling of MSCs revealed large 
variations in secretome profiles as a function of dECM (media supplementation and cell passages). 
When MSCs were seeded on dECM generated in absence of ascorbic acid, endoglin and PDGF-
AA were the only two factors that were upregulated irrespective cell passages. On the other hand, 
dECM modulation by ascorbic acid upregulated multiple factors including activing-A, ADAMTS-
1, amphiregulin, endoglin, endothelin-1, acidic FGF, IL-1, PDGF-AA, persephin, PIGF, 
prolactin, and VEGF-C across cell passages albeit with a large variation. Heterogeneous 
proangiogenic properties of MSCs as a function of tissue origins have been previously reported 
[54-56]. Studies have demonstrated that MSCs derived from bone marrow and placental chorionic 
villi exhibited significant therapeutic angiogenic activities compared to those harvested from 
adipose tissue or umbilical cord [54]. On the hand, studies have also reported that adipose tissue 
as well as umbilical cord-derived MSCs exhibit better proangiogenic profile than bone marrow-
derived MSCs [55-56].   
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To explore whether the modulated secretome profiles would translate to enhanced 
proangiogenic activities of MSCs, proliferation of HUVECs in presence of conditioned media was 
investigated. Irrespective of cell passages and media supplementation, proliferation of HUVECs 
was enhanced as compared to conditioned media collected from MSCs seeded on TCP. As a matter 
of fact, proliferation of HUVECs was found to be comparable (P3 and P5 ECM with and without 
ascorbic acid) or higher (P4 ECMs) than the normal HUVEC culture media supplemented with 
cocktail of growth factors. Enhanced stimulatory activity of MSC-secretome can be attributed to 
endoglin, one of the factors, which was upregulated irrespective of media supplementation across 
cell passages. Endoglin, a transmembrane accessory receptor for transforming growth factor-beta 
(TGF-), promotes proliferation of endothelial cells by regulating the balance of TGF- signaling 
through ALK5 and ALK1 receptors [57]. In addition, angiopoietin-1 (Ang-1) and endothelin-
1(ET-1), which were primarily upregulated in MSC secretome obtained from P4 ECMs may 
contribute to higher proliferation of HUVECs. Ang-1 has drawn attention in clinical applications 
by virtue of its ability to promote blood vessel reconstruction. Ang-1 has been shown to promote 
proliferation of endothelial cells through activator protein -1 (AP-1) dependent autocrine 
production of IL-8 [58].  
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Chapter 5: Characterization of Hybrid Hydrogels 
Introduction 
 The goal of this research is to fabricate a biomaterial capable of recapitulating the 
multifactorial aspects of extracellular components of the stem cell environment to improve the 
therapeutic efficacy of MSCs. Focus was placed on creating a hybrid hydrogel to address this goal. 
This biomaterial was chosen due to its hydrophilicity, tailorability and structural similarity to 
native tissue. Hydrogels can be synthesized by a variety of synthetic or natural polymers, and the 
type should be selected to best fit its target application. In this research, the selected hydrogel 
polymer to be used as the backbone was alginate. 
 Alginate, a natural polymer derived from seaweed, is extensively used throughout many 
biomedical applications due to its low toxicity, low cost, stability, and biocompatibility [59]. One 
of the most attractive properties of using alginate is its ease of gelation when introduced to an 
environment with divalent cations. Alginate is a linear polysaccharide that is comprised of 1,4-
linked α-L-guluronate (G) and ß-D-mannuronate (M) subunits. Once in contact with cations 
(calcium, barium, and strontium ions), the cations covalently bind the G blocks to form a “egg-
box”-like hydrogel [60]. Depending on the cations used to gel the alginate, it can result in different 
structural properties. For instance, using barium opposed to calcium will result in more rigid gels 
[60]. For the purpose of this research, calcium ions were used to stimulate gelation. Because this 
hydrogel will host stem cells during its application, a rigid gel would not be ideal. Additionally, it 
has been shown that crosslinking alginate using calcium ions can encourage cell proliferation [61].  
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In an attempt to fabricate a biomaterial that can better harness the multifactorial aspects of 
the stem cell environment, this chapter explores the development of hybrid hydrogel by combining 
ECM from cultured MSCs with alginate hydrogels. The following experiments collected dECM 
from tissue culture and used this collection to fabricate hydrogels with 30 µg/mL of ECM proteins.  
Three main material properties of dECM-alginate hydrogels were characterized in the 
following experiments. The swelling capacity of hydrogels is an important parameter to analyze 
because this characteristic controls cell migration and diffusion throughout the hydrogel network. 
Additionally, in order to have a hydrogel to be successful in tissue regeneration, the biomaterial 
must be retain its integrity for a long period of time. Thus, degradation of dECM gels was analyzed. 
Lastly, the diffusion of biomolecules released by MSCs encapsulated within hydrogels is important 
for tissue regeneration, we also studied the diffusion of macromolecules from the gels. These 
common hydrogel properties were then compared to dECM-free alginate hydrogels to explore 
whether incorporation matrix proteins affect the hydrogel properties. 
 Properties of hydrogels are influenced by the concentration of polymer used. For instance, 
a previous study demonstrated the variances in material properties (swelling, stiffness and 
stability) when alginate concentration was varied from 0.5 to 1.5% in order to create optimized 
hydrogels to support neural growth [62]. Therefore, in addition to introducing dECM into the 
hydrogels and analyzing their properties, the concentration of alginate was also differed in order 
to explore the alterations in the material properties. The concentrations of alginate were varied 
from 2.5% (w/w) to 7% (w/w).  
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Methods 
Collection of dECM 
MSCs were cultured in T75 flasks and decellularized as described earlier. dECM was 
scraped with a cell scraper, transferred into 0.02 N acetic acid (Fisher Scientific, USA), and 
sonicated to homogenize the contents. Samples were lyophilized, reconstituted in 300 μL DPBS, 
and the total protein in each sample was quantified with a bicinchoninic acid (BCA) protein assay 
(Thermo Scientific, USA).  
Coomassie Blue  
Coomassie blue staining was tested on dECM samples collected and prepared from T75 
flasks as described before. Laemmli Sample Buffer (Bio-Rad, USA) supplemented with reducing 
agent, 2-mercaptoethanol (Sigma-Aldrich, Japan), was added to the samples, heated, centrifuged, 
and then loaded in Precast Gel (Bio-Rad). Fibronectin (Sigma-Aldrich, USA) was loaded as a 
protein control. Following electrophoresis, the gels were stained with Coomassie Brilliant Blue 
(Thermo Scientific). Visualization was carried out with Bio-Rad ChemiDoc system. 
Hydrogel Fabrication 
Three stock concentrations (2.5%, 5%, 7% (w/w)) of alginate solutions were prepared by 
diluting alginic acid sodium salt (Alfa Aesar, low viscosity) in H2O. When making the hydrogels, 
200 µL of these alginate solutions were dispensed into the wells of 48 well plates. 0.5M calcium 
chloride (CaCl2, Alfa Aesar) was added on top of pre-solution in excess (500 µL) to encourage 
crosslinking and gel formation. Crosslinking was carried out for 5 minutes at room temperature 
followed which the solution was removed. Gels were then washed with dPBS for 5 minutes. To 
fabricate hybrid gels, dECM was added to the wells of the already dispensed alginate so as to 
achieve a final concentration of 30 µg/mL dECM protein per gel. Pre-gel solution was thoroughly 
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mixed with the dECM aliquot to ensure that matrix proteins are distributed throughout the solution 
prior to crosslinking. dECM gels were then crosslinked and washed as described before.  
Swelling Ratio 
Following fabrication in 48 well plates, the hydrogels were incubated in 500 µL of dPBS 
at room temperature. After three days of incubating, gels were collected, and surfaces were dried 
off with a kimwipe. The weights of the swollen gels were recorded. The gels were then dried at 
50⁰C for 24 h, and the dry weights were measured. Swelling ratio was calculated from the ratio of 
wet weight to dry weight. 
Degradation 
To investigate the integrity of the hydrogels, the initial weights of the gels were recorded 
post-fabrication (day 0). The gels were then incubated in 500 µL of collagenase (Type I, 2.5 
units/mL) and the weights of the gels were measured after 2, 4, 6, and 8 days. Degradation was 
calculated by taking the ratio of sample weights at different time points to the weights recorded on 
day 0. 
Diffusion 
50 µg/mL fluorescein isothiocyanate (FITC)-dextran (150,000 kDA, Sigma Aldrich, USA) 
was added to pre-polymer solutions to fabricate macromolecule-laden gels. The gels were washed 
in dPBS for 5 min on an orbital shaker to remove dextran molecules from the gel surfaces. dPBS 
was then aspirated and stored (t=0). 500 µL of dPBS was then added to each hydrogel, and samples 
were placed on shaker. dPBS was then collected after 1, 3, 5, and 24 h and replaced with fresh 
dPBS. Collected samples were analyzed using SpectraMax M3 fluorescence spectrometer. 
To determine the mechanism of dextran diffusion through the hydrogels, the release of 
macromolecules was fitted into Korsmeyer-Peppas model given by the following equation: 
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𝐹 =
𝑀𝑡
𝑀0
= 𝑘1𝑡
𝑛 
where, F is the fractional release of the molecule, 𝑀𝑡 is the amount of dextran released at any time 
point, 𝑀0 is the total mass of dextran that was encapsulated within the initial hydrogels, 𝑘1 is the 
kinetic constant, t is the release time, and n is the diffusional exponent. For n ≤ 0.5, the transport 
of macromolecules is regulated by diffusion, 0.5 ≤ n ≤ 0.9 both by diffusion as well as polymer 
relaxation/erosion, and for n≥ 0.9, the transport of molecules is governed via polymer chain 
relaxation/erosion. The data fitting was carried out on the first 60% cumulative release when 
𝑀𝑡
𝑀0
 = 
0.6. The effective diffusivity (D, cm2/s) of the molecules is related to the cumulative release by 
the following equation: 
𝑀𝑡
𝑀0
= 4 ∗ (
𝐷𝑡
𝜋𝐿2
)𝑛 
Where L is the thickness (cm). The diffusivity can then be related to Korsmeyer-Peppas constants: 
𝐷 = 𝜋𝐿2(
𝑘1
4
)1/𝑛 
Results 
 To confirm that dECM proteins were present in the solution after scraping the matrix off 
the flasks, Coomassie blue staining was utilized by using fibronectin as the protein control. As 
seen in Figure 9, faint bands matching those of fibronectin were found in the reconstituted dECM 
solutions collected from P3-P5 MSCs.  
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Figure 9. Coomassie blue staining of fibronectin content in collected and reconstituted dECM samples 
from P3-P5 MSCs. For each sample, faint bands matching to those of the fibronectin control indicate that 
ECM proteins were successfully collected off of cell culture flask. 
 
Images were captured of the fabricated hydrogels to illustrate the morphological and 
structural differences when introducing dECM into the biomaterial. As depicted in Figure 10 A-
C, dECM hydrogels do not exhibit the spherical shape that the dECM-free gels have. This, in turn, 
greatly affected the gel thickness as measured with a caliper and shown in Figure 10 D-E. For both 
dECM positive and negative gels, the concentration of alginate did not significantly affect the 
shape or size.  
 
 
 
 
 
Fibronectin P3 dECM P4 dECM P5 dECM 
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Figure 10. Images of alginate hydrogels fabricated without (A) and with (B) dECM (30 µg/mL). 
Concentration of alginate used within gels were 2.5%, 5% and 7% (w/w). The addition of dECM within 
scaffolds disrupted the spherification of hydrogels (C), resulting in less thick gels (D, E). Percent alginate 
did not impact the shape or size of gels. 
 
 The swelling capacity of dECM hydrogels (+dECM) was analyzed by taking the ratio of 
the weight of the swelled gel over the dry weight. The swelling ratio of hydrogels without dECM 
(- dECM) was also recorded as a control. As seen in Figure 11, the swelling ratio remained 
unchanged with the introduction of dECM into the structure. It was also observed that increasing 
the alginate concentration within the hydrogels decreased its swelling capacity. This is probably 
because increasing the concentration also increases the number of crosslinks present within the 
hydrogel network. An increased number of crosslinks limits the hydrogel’s capacity for water to 
infiltrate and swell the gel. 
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Figure 11. Swelling ratio of alginate hydrogels fabricated with (+dECM) and without (-dECM) dECM. 
Concentrations of alginate used were 2.5%, 5%, and 7% (w/w). Error bars are the standard deviation of 2 
independent experiments. 
 
 The integrity of dECM-alginate hydrogels was investigated by incubating the gels in 
collagenase for a period of 8 days and then analyzing their degradation characteristic (Figure 12). 
The data is represented as a ratio of sample weights at different time points to the weights recorded 
on day 0. Results were compared to the degradation of dECM-free alginate hydrogels. Regardless 
of the alginate concentration and inclusion of dECM, hydrogels were relatively stable throughout 
the duration of the experiment. 7% alginate hydrogels with and without dECM retained their 
structure best in comparison to all other gels. In case of 2.5% and 5% alginate hydrogels, the 
addition of dECM into the scaffold enhanced the integrity of gels as manifested from reduced 
degradation of the gels compared to gels without dECM. 
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Figure 12. Degradation of alginate hydrogels. Alginate concentrations varied from 2.5%, 5% and 7% 
(w/w). Hydrogels were also fabricated with (+dECM) and without (-dECM) dECM. Data is presented as a 
ratio of gel weights at certain time points to the weights recorded on day 0. Error bars are standard deviation. 
 
 The diffusivity of macromolecules from dECM-alginate hydrogels was calculated after 
measuring the concentration of FITC-dextran molecules diffusing out of the gels at certain time 
points (1, 3, 5, and 24 hours). Figure 13 below depicts the cumulative release of dextran as a 
function of time. The figure indicates that 2.5% alginate with dECM had the highest diffusion of 
dextran with around 45% of dextran release during the incubation time of 24 hours. Calculated 
diffusion coefficients are found in Table 1 below. When comparing the diffusivity of dextran from 
different dECM hydrogels to hydrogels without the matrix proteins, the inclusion of dECM 
reduced the diffusion coefficient. The influence of incorporation of dECM was most prominent in 
the 5% and 7% alginate gels.  
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Figure 13. Percentage of cumulative dextran released from alginate hydrogels (2.5%, 5% 7%) made with 
(+ dECM) and without (- dECM) matrix proteins over an incubation time of 24 hours. Error bars are the 
standard deviation of the results from three hydrogels per condition. 
 
Table 1. Calculated values of diffusion coefficient of hydrogels. Alginate hydrogels (2.5%, 5%, and 7%) 
were fabricated with (+dECM) and without (-dECM) 30 µg/mL dECM. Coefficient is presented as average 
of three hydrogel results ± standard deviation. 
 
 
 
Discussion 
 Coomassie blue staining revealed that the presence of fibronectin in the dECM samples. It 
was observed that the intensities of the fibronectin bands were lower for dECM samples collected 
Alginate (w/w%) - dECM + dECM
2.5 1.870±0.578 1.124±0.306
5 2.098±0.806 0.689±0.210
7 1.444±0.282 0.738±0.165
Diffusion Coefficient (cm²/s)
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from harvesting higher passage MSCs. This corroborates with the previous findings in Chapter 3 
that indicated higher passage MSCs deposit lower matrix at reduced concentrations. 
 Incorporation of dECM with alginate pre-polymer solution interrupted with the spherical 
structure/droplet formation. Spherification of alginate occurs when the G-blocks interact with 
cations, creating divalent salt bridges between polymers. Such salt bridges form a thin, but firm 
outer membrane that induces alginate to construct spheres, leaving the center only partially 
crosslinked [63]. As illustrated in Figure 10A-E, introducing dECM to alginate resulted in the 
formation of cylindrical hydrogels as opposed to spheres. It is suspected that surface tension has a 
role in this alteration of structure. 
Next, we investigated the influence of introduction of dECM in different matrix properties 
including swelling ratio, integrity, and diffusion properties of alginate gels.  While increase in 
alginate concentration reduced swelling ratio of the gels irrespective the presence and absence of 
dECM. Typically, when hydrogels are placed into an aqueous environment, osmotic driving forces 
power the influx of fluid into the matrix. Cohesive forces, which are exerted by the hydrogel’s 
polymer strands, resist the expansion of the scaffold, and together, osmotic and cohesive forces 
create an equilibrium swelling [64]. Generally, the amount of fluid absorbed and extent of swelling 
capacity is dependent on crosslinking density within the hydrogels. Scaffolds with a high 
crosslinking density will exhibit a lower swelling capacity than low crosslinked gels [64]. 7% 
alginate gels with the highest crosslinking density resulted in the lowest swelling ratio. On the 
other hand, the 2.5% gels had the highest swelling capacity. Interestingly, no difference in the 
swelling ratio of hybrid and alginate gels was observed. This suggests that dECM is not 
interrupting the native alginate hydrogel properties. 
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 Investigations into the degradation characteristics of alginate and hybrid gels exhibited 
relative stability throughout the incubation period of 8 days. All hydrogels maintained 65% or 
more of its original weight. The hydrogels fabricated with 7% alginate irrespective of dECM 
displayed the least degradation when comparing to the other alginate concentrations. Further, the 
degradation results of the 7% alginate gels alluded to be unaffected by the addition of dECM as 
their results were consistent to each other. On the other hand, the 2.5% and 5% alginate hydrogels 
suggest a different conclusion. The addition of dECM into the scaffold appeared to enhance the 
gels durability as less degradation was observed for the 2.5% and 5% gels fabricated with dECM 
than the gels made without dECM. 
 The long-term goal is to create MSC-laden scaffolds for efficient tissue restoration. For 
such a system to work efficiently, transport of bioactive molecules, released by encapsulated 
MSCs, is critical for recruiting the endogenous cells to the target site. To investigate the transport 
of marcromolecules from the gels, dextran molecules tagged with FITC as a model molecule was 
encapsulated with alginate gels and the release was monitored over time. Among all gels, 2.5% 
alginate with dECM displayed the highest percent release of dextran after 24 hours. Dextran 
release was fitted into the Korsmeyer-Peppas transport model, which is a simple release 
mechanism used to describe drug release from a polymeric system [65]. The addition of dECM 
significantly reduced the diffusivity of dextran from the gels with this outcome being most 
emphasized for the 5% and 7% alginate gels. Such results suggest that dECM proteins integrated 
within the alginate matrix could be hindering the ease of diffusion.  
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Chapter 6: Printability of dECM Hydrogels 
Introduction 
 Three-dimensional (3D) printing, also referred to as additive manufacturing, is a process 
that builds a 3D object from a computer-aided design (CAD) file using additive processes. 
Conventionally, an additive process lays down successive layers of material until the 3D object is 
built. Within this type of manufacturing, there exists a branch called bioprinting that builds 3D 
scaffolds made of biomaterials, cells, and other biomolecules [66]. This process can be 
advantageous in the field of tissue engineering because the prints can be designed to selectively 
deposit cells or biomolecules to fit applications with better precision. Gradients of chemical and 
biophysical cues can be built into the design to induce and improve regeneration. Further, 3D 
scaffolds can be printed in precise, complex designs that other conventional fabrication methods 
cannot achieve. Typical scaffold creation methods, such as electrospinning and gas foaming, 
cannot accurately control the shape, pore size, and internal network like bioprinting can [67]. 
Lastly, bioprinting generally uses hydrogels as the material dispensed to create the scaffolds and 
is termed as a bioink. 
 Due to the obvious benefits of bioprinting, it was desired to be able to print the hybrid 
hydrogels developed within this research. Therefore, the printability of the dECM-alginate 
hydrogels/bioinks was investigated in this chapter. For all concentrations of alginate, images of 
final prints were captured, and through these images, the printed strand widths, spreading ratio of 
the bioinks and print accuracy were measured. The bioinks were printed using a pneumatic based 
extrusion bioprinter called INKREDIBLE. Since this bioprinting method is dependent on pressure, 
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the following experiment investigated the effect of printing pressure and documented the optimal 
printing pressure for each bioink. 
Methods 
Bioprinting Process 
 Using an INKREDIBLE bioprinter (Cellink, Sweden), all printing was performed at room 
temperature (25º C). Pre-crosslinked solutions with and without dECM had two drops of food 
coloring added to them for visual clarity post-print. 2.5% concentrations were stained green, 5% 
concentrations were stained red, and 7% concentrations were stained blue. Bioinks were then 
loaded into a 3 mL syringe (BD, USA), and using a female-female luer lock adapter, the inks were 
transferred into printing cartridges. 25 Gauge (25 G, diameter 0.25 mm) high precision needles 
were fixed to the end of the cartridges. The pressure was selected to fit both the viscosity of the 
ink and the needle. Printing speeding was set to 6 mm/s, and prints were dispersed onto a glass 
petri dish. Print bed and nozzle were homed before every print, setting the zero position for x and 
y-axes, and the distance between the glass petri dish and the needle was calibrated to give the zero 
position for the z -axis. 
Printability 
 The printability of alginate hydrogels with and without dECM was analyzed by printing a 
10x10mm square with four inner quadrants. The dimensions of the file can be seen in Figure 14 
below. Inner and perimeter lines were designed to be 0.25 mm thick. Printing pressure was varied 
independently for each hydrogel concentration to examine the effects of pressure on printability. 
The printing pressures used for the 2.5% alginates was 2 and 5 kPa. The printing pressures tested 
for the 5% alginates was 8, 10, 12, and 15 kPa. Lastly, the pressures examined for the 7% alginates 
was 12, 14, 18, 24, and 32 kPa. Images of each print were captured, and using ImageJ (NIH, USA), 
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the dimensions of the printing results were measured. Three tests of printability were examined 
through the recorded measurements: 
1) Printing Accuracy - Knowing the dimensions of the design, printing accuracy was 
determined by taking multiple width and length measurements of the actual print on 
ImageJ. These values were then averaged to get an average length of the sides (La). The 
average length of the printed sides was compared to the actual design’s side lengths (L) 
to obtain a printing accuracy. The following equation was used: 
𝑃𝑟𝑖𝑛𝑡𝑖𝑛𝑔 𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 (%) = (1 −
|𝐿𝑎 − 𝐿|
𝐿
)  𝑥 100 
2) Strand Width – Multiple measurements of the strand thickness were taken. 
Measurements were taken from both the inner and perimeter lines. All values were then 
averaged. 
3) Spreading Ratio – Individual strand width measurements were compared to the needle 
diameter through the following equation. The spreading ratio values per strand width 
were then averaged for each printed hydrogel and presented with standard deviation.  
𝑆𝑝𝑟𝑒𝑎𝑑𝑖𝑛𝑔 𝑅𝑎𝑡𝑖𝑜 =  
𝑃𝑟𝑖𝑛𝑡𝑒𝑑 𝑆𝑡𝑟𝑎𝑛𝑑 𝑊𝑖𝑑𝑡ℎ
𝑁𝑒𝑒𝑑𝑙𝑒 𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟
 
 
 
Figure 14. Schematic of the designed structure to test printability. 
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Results and Discussion 
Printability of 2.5% Alginate With and Without dECM 
Figure 15 depicts the print outcomes from using 2.5% alginate concentrations as ink. For 
all cases, the images revealed that this concentration results in a solution that is too liquid-like to 
be used as a bioink. When the pressure was 2 kPa, one quadrant of the designed structure was 
visible in the printing of 2.5% alginate with dECM. However, there was quite a bit of pooling, 
making this condition unprintable. Further, all four quadrants were visible in the print result of 
2.5% alginate without dECM, but two minutes post printing, the semi-defined structure settled 
into a pool of solution. Printing at 5 kPa of pressure, neither the dECM or dECM-free solutions 
retained the shape it was printed in, resulting in a pool of liquid. Such printing pressure in 
combination of ink composition was considered unprintable. Therefore, it was concluded that 
2.5% alginate concentrations were unprintable despite the addition of dECM and printing 
pressure. 
 
                
 
Figure 15. Images of the printed results, using 2.5% alginate with (+dECM) and without (-dECM) ECM 
proteins. Printing pressure (2 and 5 kPa) was varied to analyze the effect of pressure. 
 
2 kPa 5 kPa 
2.5% alginate 
+ dECM 
2.5% alginate 
- dECM 
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Printability of 5% Alginate With and Without dECM 
Unlike the 2.5% alginate concentrations, the 5% gels irrespective of dECM addition 
showed better printability. Looking at the results in Figure 16, all prints visibly reflected the shape 
of the design with no obvious failures.  
 
 
           
 Figure 16. Images of the printed results, using 5% alginate with (+dECM) and without (-dECM) ECM 
proteins. Printing pressure (8, 10, 12, and 15 kPa) was varied to analyze the effect of pressure on the 
printability of the inks. 
  
Both visible results and quantitative analysis indicate that increasing the printing pressure 
results in a thicker printed strand width (Figure 17A). This is expected because at a higher printing 
pressure, the needle dispenses more material while the print speed stays the same. Comparing the 
strand widths between the gels with and without dECM, there was no difference, suggesting dECM 
is not impacting the printability of the material. The spreading ratio indicated the same conclusion 
as the values remained constant regardless of dECM addition (Figure 17B).  
 
 
8 kPa 10 kPa 12 kPa 15 kPa 
5% alginate 
+ dECM 
5% alginate 
- dECM 
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Figure 17. Printabillity of 5% alginate made with (+dECM) and without (-dECM) ECM proteins. A) 
Average strand widths of the printed structure. B) Spreading ratio of the printed gels to analyze how much 
the print strand spread in comparison to the original needle diameter. Error bars represent standard 
deviation.  
 
Table 2 expressed the values of printing accuracy gathered from the outer dimensions of 
the printed gels. Likewise, the printing accuracies are comparable between the solutions with and 
without dECM. Focusing on the dECM gels, the printing accuracy, strand width, and spreading 
ratio suggest that printing at 8 kPa is the optimal printing condition. Print images also support this 
fact; the lines of the 8 kPa print exhibited a thin and more uniform diameter throughout in 
comparison to the higher printing pressures. On the other hand, without dECM, the gel printed at 
10 kPa exhibited the best printing accuracy, suggesting this condition to be the optimal pressure. 
Even though the strand width and spreading ratio results of the 10 kPa print were slightly larger in 
comparison to the 8 kPa print, the images support that 10 kPa is the optimum condition. The 
dECM-free gel printed at 8 kPa had variable strand widths throughout the print, where the 10 kPa 
print exhibited more uniform diameters. Therefore, it was concluded that 5% alginate with dECM 
had the best printability when printed at 8 kPa, and the 5% alginate without dECM proteins printed 
best at 10 kPa. 
 
 
A B 
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Table 2. Calculated values of printing accuracy (%) when varying the printing pressure. The inks compared 
were 5% alginates with (+dECM) and without dECM (-dECM). Printing accuracy was determined by 
comparing the printed square’s side length to the design’s side lengths. Results were expressed as average 
± standard deviation.  
 
 
 
Printability of 7% Alginate With and Without dECM 
 Examining the printability of 7% alginate inks, a different range of printing pressures had 
to be selected as opposed to the pressures that were used when printing the 5% concentrations. 
This is due to the fact that the 7% alginates have a higher viscosity, requiring more pressure for 
the gel to be dispensed through the fine needle. Thus, the tested printing pressures for the 7% 
printability analysis were 12, 14, 18, 24, and 32 kPa. Images of the printed constructs, both with 
dECM and without dECM, can be seen in Figure 18. Initially, it can be observed that the printed 
gels loaded with dECM are not as thin as the as the printed gels without dECM. However, the 
dECM-free ink printed at 12 kPa and 14 kPa do not have complete structures; these prints are 
missing segments, indicating that the printing pressure was too low to allow consistent output of 
gel from the needles. Both cases were considered to be unprintable, and further printability was 
not analyzed on these two conditions. Although dECM-free ink was considered to be unprintable 
at 12 and 14 kPa, the addition of dECM into 7% alginate improved printability at these pressures. 
A complete structure with uniform line widths were exhibited when dECM gels were printed at 12 
and 14 kPa. This effect could be advantageous when introducing cells to the inks. As shown in a 
previous study, cells are sensitive to high printing pressures due to increased stress that is put on 
Pressure (kPa) 5% + dECM 5% - dECM
8 55.37 ± 2.29 55.28 ± 1.64
10 50.56 ± 1.80 58.16 ± 0.13
12 48.94 ± 2.51 48.82 ± 1.05
15 34.52 ± 2.02 37.07 ± 3.98
Printing Accuracy (%)
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them [68]. Being able to print the same polymer concentration at lower pressure could possibly 
improve cell viability in future studies. 
 
   
 
Figure 18. Images of the printed results, using 7% alginate with (+dECM) and without (-dECM) ECM 
proteins. Printing pressure (12, 14, 18, 24 and 32 kPa) was varied to analyze the effect of pressure on the 
printability of the inks. 
 
 As the images implied and regardless of dECM addition, an increased printing pressure 
results in thicker strand widths (Figure 19A) and higher spreading ratios (Figure 19B). For all 
printing pressures, the dECM-free inks exhibited much lower strand widths and spreading ratios 
than the inks loaded with the ECM proteins. For instance, the inks that were printed at 18 kPa, 
dECM-alginate gels had a spreading ratio that was over 6 times larger than the needle diameter, 
whereas the purely alginate gels had a lower spreading ratio of only 2.5 times larger. These results 
suggest that the dECM is affecting the printability of the 7% alginate gels, which contradicts the 
results found with the 5% alginate inks.  
 
 
12 kPa 14 kPa 18 kPa 24 kPa 32 kPa 
7% + 
dECM 
7% - 
dECM 
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Figure 19. Printabillity of 7% alginate made with (+dECM) and without (-dECM) ECM proteins. A) 
Average strand widths of the printed structure. B) Spreading ratio of the printed gels to analyze how much 
the print strand spread in comparison to the original needle diameter. Error bars represent standard 
deviation.  
 
 As expected, the print accuracy also implies that the introduction of dECM into 7% alginate 
inks is impacting the printability (Table 3). For dECM-free inks, the printing pressure resulting in 
the best accuracy and overall results was 18 kPa. On the other hand, the ink with dECM addition 
has its best printability results with a much lower pressure of 12 kPa. Both of these inks expressed 
relatively same printing accuracy when being printed at their optimal printing pressures. Thus, it 
can be concluded that the dECM addition is influencing the inks to have improved printability 
results at lower pressures.  
 
Table 3. Calculated values of printing accuracy (%) when varying the printing pressure. The inks compared 
were 7% alginates with (+dECM) and without dECM (-dECM). Printing accuracy was determined by 
comparing the printed square’s side length to the design’s side lengths. Results were expressed as average 
± standard deviation. 
 
 
Pressure (kPa) 7% + dECM 7% - dECM
12 70.38 ± 1.04 Unprintable
14 47.46 ± 0.25 Unprintable
18 46.73 ± 0.01 73.85 ± 2.17
24 44.02 ± 0.77 56.19 ± 0.71
32 27.57 ± 0.80 50.42 ± 1.77
Printing Accuracy (%)
B A 
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Optimal Printing Parameters 
Table 4 below shows the optimum printing pressures and parameters in relation to bioink 
composition that were found in these experiments. The dECM addition into alginate inks did not 
influence the print accuracy as both the 5% and 7% alginates with and without matrix proteins 
respectively exhibited similar accuracy, but just at different printing pressures. It can be seen that 
the using 5% alginate inks results in a decreased print accuracy in comparison to the 7% inks. 
 
Table 4. Expression of optimal printing parameters with respect to bioink composition. 
  
 
As expressed in Table 4, 5% alginate with dECM exhibited the best printability at 8 kPa, 
and 7% alginate with dECM printed best at 12 kPa. The strand width, spreading ratio, and images 
of such prints can be found in Figure 20 below. Even though these were considered the optimal 
printing conditions for the inks, the spreading ratios indicate that 5% is around 4.5 times the needle 
diameter and 7% is around 2.25 times the needle diameter. These values may seem extraordinary, 
but this is to be expected since gravity acts on the dispensed inks, which causes an increase in 
width compared to needle diameter. Further, 5%-dECM ink exhibited a much higher spreading 
ratio than 7%-dECM gels. This can be explained by the difference in viscosity. Although the exact 
viscosity of these dECM-alginate inks is not formally reported in this study, 5% alginate has a 
lower viscosity due to a less dense crosslinked network and can be confirmed through handling 
the material during experimentation [69]. Thus, printing with lower viscosity inks creates a more 
Pressure (kPa) Nozzle Diameter (mm) Print Speed (mm/s) Print Accuracy (%)
2.5
5 8 0.25 6 55.37 ± 2.29
7 12 0.25 6 70.38 ± 1.04
2.5
5 10 0.25 6 58.16 ± 0.13
7 18 0.25 6 73.845 ± 2.17
Bioink
+ dECM
- dECM
Unprintable
Unprintable
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prominent pooling effect, which explains the larger strand widths for 5%-dECM gels. This effect 
can also explain the extreme pooling of 2.5% alginate gels that made that concentration 
unprintable. Therefore, due to the viscosity differences, there is a restriction to the minimum 
achievable strand width in bioprinting dependent on the material’s viscosity. The 5%-dECM gels 
may express a thicker width opposed to the 7%-dECM inks, but if printed at lower pressures, their 
structure may not complete, resulting in unprintability.  
 
 
          
Figure 20. Comparing printability results of the dECM inks (both 5% and 7% alginate) that were printed 
at the optimal printing pressures. A) Strand width, B) Spreading ratio, C) 5% alginate with dECM printed 
at 8 kPa, D) 7% alginate with dECM printed at 12 kPa. 
 
 
 
 
A B 
D C 
52 
 
Chapter 7: Conclusion 
In this study, MSC-derived matrices were generated under various conditions and 
characterized to harness the proangiogenic profile of MSCs. dECM secretion under ascorbic acid 
supplementation resulted in an increased deposition of matrix structural proteins while it was found 
that increasing passage of MSCs reduces the ECM deposition. Work reports that the presentation 
and variation of dECM composition alters MSC secretory signatures. dECM generated with media 
supplementation with ascorbic acid resulted in more upregulated angiogenic signaling of MSCs. 
dECM-alginate hybrid hydrogels were successfully synthesized with 30 µg/mL of matrix proteins 
derived from MSCs. Characterizing these gels, swelling ratio showed no difference with and 
without dECM addition, but indicated an increased swelling for lower alginate concentrations. On 
the other hand, both degradation and diffusion studies suggest that dECM addition influenced the 
material properties of the alginate hydrogels. Both the 2.5% and 5% hybrid gels exhibited more 
resistance to degradation in comparison to the gels without dECM, whereas for all concentrations 
of alginate, the addition of dECM resulted in a lower effective diffusivity of dextran molecules 
than the dECM-free counterparts. Printability studies of hybrid hydrogels showed that 2.5% 
alginate cannot be printed due to its low viscosity. Both the 5% and 7% alginates proved to be 
successfully printable, and optimum printing pressures were documented. Regardless of dECM 
addition, 5% alginate showed to have a lower print accuracy and larger spreading ratios when 
compared to the printability results of 7% alginates. When dECM was introduced into the 
alginates, the hybrid hydrogels had their optimum prints at lower printing pressures than the 
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pressures used to print the dECM-free bioinks, which can be advantageous for future studies in 
increasing cell viability through the printing process.  
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Chapter 8: Future Studies 
 The present work illustrated the composition of MSC-derived dECM from one donor. 
Future work should analyze the difference in ECM deposition from different donors in order to 
account for biological variability. We anticipate that there would be some biochemical 
heterogeneity between matrices deposited by MSCs from different donors, yet they would display 
consistent composition (i.e. share common set of proteins). Further, dECM composition and its 
effect on bioactivity of MSCs was studied by varying passage numbers from P3 to P5 and under 
ascorbic acid supplementation. However, there are other factors that can influence dECM secretion 
and its impact. For instance, oxygen tension in vivo can influence trophic factor secretion of MSCs. 
Future work involving varying oxygen tension and temporal profiling of angiogenesis related 
factors (both pro-and anti-angiogenic molecules) will permit elucidating the complex interplay 
between different microenvironmental factors in guiding angiogenesis.  
Addressing the characterization of dECM-alginate hydrogels, a few more experiments 
need to be carried out. The material properties studied in this work were swelling ratio, 
degradation, and diffusion, which leaves rheological characterization for future work. Because the 
end goal is to bioprint these hydrogels into complex, 3D constructs, the material properties need 
to be explored when the hydrogels are printed to document whether the fabrication process of 
bioprinting impacts material characteristics. Furthermore, immunostaining of dECM proteins and 
scanning electron microscope (SEM) images should be taken of printed hydrogels to gather 
information about the surface topography and composition of the bioinks.  
55 
 
The work completed in this thesis focusing on the bioprinting of hybrid dECM hydrogels 
were preliminary efforts, and future research is crucial. The fabrication of multi-layered scaffolds 
needs to be optimized by introducing the crosslinking solution into the second bioprinting nozzle. 
This would allow for precise crosslinking during the printing process rather than the current 
method of crosslinking post-print. In addition to this, printing the bioink with cells will be analyzed 
in future studies through post-printing viability studies. Once the cells are introduced into the 
dECM-alginate bioinks and successfully printed with, similar experiments exploring paracrine 
signaling and bioactivity of MSCs will be carried out to study if the hybrid hydrogel improves the 
therapeutic efficacy of MSCs. 
Lastly, the hybrid dECM-alginate hydrogels fabricated within this thesis contained 30 
µg/mL of matrix proteins. Further work will vary the dECM concentration within the gels. 
Experiments will not only study how this impacts the material properties and printability of the 
bioinks, but work will also address how varying the dECM concentration impacts viability of cells 
and paracrine signaling of MSCs when the cells are encapsulated within the hydrogel.
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